Skeletal involvement in adult patients with endogenous hypercortisolism
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Overt endogenous glucocorticoid excess is a well-recognized cause of bone loss and osteoporotic fractures. Cortisol excess inhibits bone formation, increases bone resorption, impairs calcium absorption from the gut, and affects the secretion of several hormones (in particular gonadotropins and GH), cytokines, and growth factors, influencing bone metabolism. The glucocorticoid excess mainly affects trabecular bone, leading to vertebral fractures in up to 70% of patients. Osteoporotic fractures may be the presenting symptom of an otherwise silent glucocorticoid excess and can precede the diagnosis of hypercortisolism by up to 2 yr. The removal of glucocorticoid excess leads to a recovery of bone mass which is, however, often incomplete and delayed, although it reduces the risk of osteoporotic fractures. Bisphosphonate therapy has been suggested to be useful in maintaining bone mass in these patients. Subclinical hypercortisolism, a condition of impaired hypothalamic- adrenal-axis homeostasis without the classical signs and symptoms of glucocorticoid excess, is a recently defined entity, which has been shown to be associated to increased bone resorption, bone loss, and high prevalence of vertebral fractures regardless of gonadal status. However, data about the effect of this subtle glucocorticoid excess on bone are still scarce and conflicting. Moreover, it is not yet known whether removing the cause of subclinical hypercortisolism leads to a recovery of bone mass and reduces the risk of osteoporotic fractures. Finally, recent data suggest that subclinical hypercortisolism is a common and underrated finding in patients with established osteoporosis. In summary, it is crucial to evaluate the risk of osteoporosis and fractures in patients with glucocorticoid excess; on the other hand, it also seems advisable to screen for glucocorticoid excess patients with osteoporotic fractures without known secondary causes of osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, cortisol can negatively affect bone health73 and exacerbate age-related bone density decline, possibly contributing to the development of osteosarcopenic obesity74.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [73]
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
(2018) · Wiley eBooks · doi:10.1002/9781119266594 · Cited by 1,105
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
O’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Laurence, M. (2000) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.82b7.0821087b · Cited by 675
Molecular Basis and Clinical Application of Biological Markers of Bone Turnover*
CALVO, M. S., EYRE, D. R., & GUNDBERG, C. M. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-333 · Cited by 518
Rossi, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1440 · Cited by 419
Mechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density
Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0459 · Cited by 394
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285
Huizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265
The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis
van Staa, T. P. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0019-1 · Cited by 260
Perspectives on glucocorticoid-induced osteoporosis
Canalis, E., Bilezikian, J. P., Angeli, A., & Giustina, A. (2004) · Bone · doi:10.1016/j.bone.2003.11.026 · Cited by 249
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Ohnaka, K., Taniguchi, H., Kawate, H., Nawata, H., & Takayanagi, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.025 · Cited by 198
Rubin, M. R., & Bilezikian, J. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012101 · Cited by 193
Notch 1 Impairs Osteoblastic Cell Differentiation
Sciaudone, M., Gazzerro, E., Priest, L., Delany, A. M., & Canalis, E. (2003) · Endocrinology · doi:10.1210/en.2003-0463 · Cited by 192
Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome
Hermus, A. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.2859 · Cited by 185
Centrella, M., McCarthy, T. L., & Canalis, E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4490 · Cited by 164
Chiodini, I. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1863 · Cited by 153
Self-citationTauchmanovà, L., Pivonello, R., Di Somma, C., Rossi, R., De Martino, M. C., Camera, L., Klain, M., Salvatore, M., Lombardi, G., & Colao, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0582 · Cited by 151
Normal bone mineral density following cure of Cushing's syndrome
Manning, P. J., Evans, M. C., & Reid, I. R. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01437.x · Cited by 146
Mancini, T., Doga, M., Mazziotti, G., & Giustina, A. (2004) · Pituitary · doi:10.1007/s11102-005-1051-2 · Cited by 144
Increased risk of osteoporotic fractures in patients with Cushing's syndrome
Vestergaard, P., Lindholm, J., Jorgensen, J., Hagen, C., Hoeck, H., Laurberg, P., Rejnmark, L., Brixen, K., Kristensen, L., Feldt-Rasmussen, U., et al. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460051 · Cited by 138
Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind
Manolagas, S. C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1001 · Cited by 135
Ueland, T., Bollerslev, J., Godang, K., Muller, F., Froland, S., & Aukrust, P. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450685 · Cited by 134
Di Somma, C., Pivonello, R., Loche, S., Faggiano, A., Klain, M., Salvatore, M., Lombardi, G., & Colao, A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01713.x · Cited by 124
Kristo, C., Jemtland, R., Ueland, T., Godang, K., & Bollerslev, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02067 · Cited by 118
Osteoporosis Associated with Excess Glucocorticoids
Shaker, J. L., & Lukert, B. P. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.014 · Cited by 116
Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing?s syndrome
Minetto, M. A., Reimondo, G., Osella, G., Ventura, M., Angeli, A., & Terzolo, M. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1616-3 · Cited by 112
Malabsorption of calcium in corticosteroid-induced osteoporosis
Morris, H. A., Need, A. G., O’Loughlin, P. D., Horowitz, M., Bridges, A., & NORDIN, B. E. C. (1990) · Calcified Tissue International · doi:10.1007/bf02563820 · Cited by 111
Advanced Imaging Assessment of Bone Quality
Genant, H. K., & Jiang, Y. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.038 · Cited by 107
Stewart, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490163 · Cited by 105
Evidence for Decreased Tubular Reabsorption of Calcium in Glucocorticoid-Treated Asthmatics
Reid, I. R., & Ibbertson, H. K. (1987) · Hormone Research · doi:10.1159/000180820 · Cited by 104
11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone
Cooper, M. S., Blumsohn, A., Goddard, P. E., Bartlett, W. A., Shackleton, C. H., Eastell, R., Hewison, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022025 · Cited by 96
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease
Di Somma, C., Colao, A., Pivonello, R., Klain, M., Faggiano, A., Tripodi, F. S., Merola, B., Salvatore, M., & Lombardi, G. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00486.x · Cited by 95
Torlontano, M., Chiodini, I., Pileri, M., Guglielmi, G., Cammisa, M., Modoni, S., Carnevale, V., Trischitta, V., & Scillitani, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5856 · Cited by 91
Self-citationOsella, G. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3303 · Cited by 87
Sartorio, A., Conti, A., Ferrero, S., Giambona, S., Re, T., Passini, E., & Ambrosi, B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380146 · Cited by 84
Chiodini, I., Guglielmi, G., Battista, C., Carnevale, V., Torlontano, M., Cammisa, M., Trischitta, V., & Scillitani, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031413 · Cited by 82
Self-citationOsteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome.
OHMORI, N., NOMURA, K., OHMORI, K., KATO, Y., ITOH, T., & TAKANO, K. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.1 · Cited by 81
Tauchmanova, L., Rossi, R., Nuzzo, V, del Puente, A., Esposito-del Puente, A., Pizzi, C., Fonderico, F., Lupoli, G., & Lombardi, G. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450241 · Cited by 79
Histomorphometric analysis of glucocorticoid-induced osteoporosis
Carbonare, L. D., Bertoldo, F., Valenti, M. T., Zenari, S., Zanatta, M., Sella, S., Giannini, S., & Cascio, V. L. (2005) · Micron · doi:10.1016/j.micron.2005.07.009 · Cited by 76
Bone loss rate in adrenal incidentalomas: a longitudinal study
Chiodini, I., Torlontano, M., Carnevale, V., Guglielmi, G., Cammisa, M., Trischitta, V., & Scillitani, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8022 · Cited by 69
Self-citationBone metabolism and mass in women with Cushing’s syndrome and adrenal incidentaloma
Francucci, C. M., Pantanetti, P., Garrapa, G. G., Massi, F., Arnaldi, G., & Mantero, F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01602.x · Cited by 65
Godang, K., Ueland, T., & Bollerslev, J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410126 · Cited by 64
Quantitative computed tomography at the axial and peripheral skeleton
Guglielmi, G., Schneider, P., Lang, T., Giannatempo, G. M., Cammisa, M., & Genant, H. K. (1997) · European Radiology · doi:10.1007/pl00006862 · Cited by 63
Chiodini, I., Tauchmanovà, L., Torlontano, M., Battista, C., Guglielmi, G., Cammisa, M., Colao, A., Carnevale, V., Rossi, R., Di Lembo, S., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020399 · Cited by 63
Self-citationHadjidakis, D., Tsagarakis, S., Roboti, C., Sfakianakis, M., Iconomidou, V., Raptis, S. A., & Thalassinos, N. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01676.x · Cited by 60
Biochemical Markers of Bone and Collagen Turnover in Acromegaly or Cushing's Syndrome
Piovesan, A., Terzolo, M., Reimondo, G., Pia, A., Codegone, A., Osella, G., Boccuzzi, A., Paccotti, P., & Angeli, A. (1994) · Hormone and Metabolic Research · doi:10.1055/s-2007-1001672 · Cited by 58
Osella, G., Reimondo, G., Peretti, P., Alì, A., Paccotti, P., Angeli, A., & Terzolo, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7178 · Cited by 54
Ghrelin, Hypothalamus-Pituitary-Adrenal (HPA) Axis and Cushing's Syndrome
Giordano, R., Picu, A., Broglio, F., Bonelli, L., Baldi, M., Berardelli, R., Ghigo, E., & Arvat, E. (2004) · Pituitary · doi:10.1007/s11102-005-1173-6 · Cited by 49
Luisetto, G., Zangari, M., Camozzi, V., Boscaro, M., Sonino, N., & Fallo, F. (2001) · Osteoporosis International · doi:10.1007/s001980170025 · Cited by 45
Kristo, C., Godang, K., Ueland, T., Lien, E., Aukrust, P., Froland, S., & Bollerslev, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460389 · Cited by 45
Wüster, C., Heilmann, P., Pereira-Lima, J., Schlegel, J., Anstätt, K., & Soballa, T. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211986 · Cited by 44
Quantitative Ultrasound of Bone and Markers of Bone Turnover in Cushing's Syndrome
Cortet, B., Cortet, C., Blanckaert, F., D’Herbomez, M., Marchandise, X., Wemeau, J. L., Decoulx, M., & Dewailly, D. (2001) · Osteoporosis International · doi:10.1007/s001980170143 · Cited by 42
Kann, P., Laudes, M., Piepkorn, B., Heintz, A., & Beyer, J. (2001) · Clinical Rheumatology · doi:10.1007/s100670170099 · Cited by 34
Osteocalcin Levels in Cushing's Disease before and after Treatment
Sartório, A., Ambrosi, B., Colombo, P., Morabito, F. C., & Faglia, G. (1988) · Hormone and Metabolic Research · doi:10.1055/s-2007-1010755 · Cited by 29
Karavitaki, N., Ioannidis, G., Giannakopoulos, F., Mavrokefalos, P., & Thalassinos, N. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01968.x · Cited by 28
Khanine, V., Fournier, J. J., Requeda, E., LUTON, J. P., Simon, F., & Crouzet, J. (2000) · PubMed · Cited by 27
Hypercorticism blunts circadian variations of osteocalcin regardless of nutritional status
Vergely, N., Lafage‐Proust, M., Caillot‐Augusseau, A., Millot, L., Lang, F., & Estour, B. (2002) · Bone · doi:10.1016/s8756-3282(01)00677-9 · Cited by 24
Bardet, S., Rohmer, V., de Casson, F. B., Coffin, C., Ronci, N., Sabatier, J., Lecomte, P., Audran, M., Henry-Amar, M., & Tabarin, A. (2002) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(02)00606-9 · Cited by 23
Sartorio, A., Conti, A., Ferrario, S., Passini, E., Re, T., & Ambrosi, B. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.849.419 · Cited by 19
Scillitani, A., Dicembrino, F., Chiodini, I., Minisola, S., Fusilli, S., Giorgio, A. D., Garrubba, M., D’Aloiso, L., Frusciante, V., Torlontano, M., et al. (2002) · Osteoporosis International · doi:10.1007/s001980200115 · Cited by 15
Self-citationIncidentaloma, glucocorticoid excess and low bone mineral density: a coincidence?
Devogelaer, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450237 · Cited by 9
Glucocorticoid-Induced Osteoporosis: A Clinician's Perspective
Graves, L., & Lukert, B. P. (2004) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1385/bmm:2:2:079 · Cited by 8
Research works printed but not linked: 1
- Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 2005, 34: 341–56. · DOI
Cited by
Valassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0272 · Cited by 402
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“Furthermore, cortisol can negatively affect bone health 73 and exacerbate age-related bone density decline, possibly contributing to the development of osteosarcopenic obesity 74 .”
Chiodini, I., Morelli, V., Masserini, B., Salcuni, A. S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0468 · Cited by 168
Self-citationResmini, E., Minuto, F., Colao, A., & Ferone, D. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0112-9 · Cited by 147
“corticoid excess leads to a recovery of bone mass which is, however, often incomplete and delayed, although it reduces the risk of osteoporotic fractures [32].”
BackgroundEller-Vainicher, C., Morelli, V., Ulivieri, F. M., Palmieri, S., Zhukouskaya, V. V., Cairoli, E., Pino, R., Naccarato, A., Scillitani, A., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1648 · Cited by 143
Self-citation
Metadata
- Authors
- Chiodini, I., Torlontano, M., Carnevale, V., Trischitta, V., & Scillitani, A.
- Affiliations
- University of Milan (IT)
- Casa Sollievo della Sofferenza (IT)
- Corresponding author
- Scillitani, A.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2008-03
- Volume
- 31
- Issue
- 3
- Pages
- 267-276
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2152174465
- Cited by
- 78
- References
- 69
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 2 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 3 · 2014: 6 · 2013: 6 · 2012: 5
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- endogenous hypercortisolism, Cushing's syndrome, subclinical hypercortisolism, osteoporosis, osteoporotic fractures, bone loss, bone resorption, trabecular bone, vertebral fractures, bone metabolism, hypothalamic-pituitary-adrenal axis, bisphosphonates, fracture screening
- MeSH terms
- Adult, Bone Diseases, Bone Resorption, Calcium, Cushing Syndrome, Female, Gonadotropins, Humans, Intestinal Absorption, Male, Osteoporosis, Risk Factors, Biomarkers, Bone Density, Spinal Fractures, Bone Remodeling, Human Growth Hormone, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.